Medicare Enrolled

Dr. Wendy Weinstein, MD

Psychiatry · Buffalo, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
ELM AND CARLTON ST., Buffalo, NY 14263
7168452300
In practice since 2006 (20 years)
NPI: 1679523484 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Weinstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Weinstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Weinstein

Dr. Wendy Weinstein is a psychiatry specialist in Buffalo, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Weinstein performed 387 Medicare services across 138 unique beneficiaries.

Between the years covered by Open Payments, Dr. Weinstein received a total of $408,217 from 37 pharmaceutical and/or device companies across 1568 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Weinstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 35% volume in NY $408,217 industry payments

Medicare Practice Summary

Medicare Utilization ↗
387
Medicare services
Top 35% in NY for psychiatry
138
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~19 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
217 $54 $106
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
132 $58 $124
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
22 $133 $236
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
16 $88 $178
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$408,217
Total received (2018-2024)
Avg $58,317/year across 7 years
Top 1% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
1,568
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$387,194 (94.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,720 (3.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,303 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$90,478
2023
$111,122
2022
$35,705
2021
$27,423
2020
$17,652
2019
$47,955
2018
$77,883

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Vanda Pharmaceuticals Inc.
$31,144
Otsuka America Pharmaceutical, Inc.
$28,258
ABBVIE INC.
$25,969
E.R. Squibb & Sons, L.L.C.
$3,616
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$361
Alkermes, Inc.
$219
Lundbeck LLC
$205
Neurocrine Biosciences, Inc.
$164
Janssen Pharmaceuticals, Inc
$164
Axsome Therapeutics, Inc.
$145
Teva Pharmaceuticals USA, Inc.
$86
Corium, LLC
$54
IDORSIA PHARMACEUTICALS US INC
$45
Biogen, Inc.
$32
Noven Therapeutics, LLC
$14
Top 3 companies account for 94.4% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$132,334
AbbVie Inc.
$81,838
Sunovion Pharmaceuticals Inc.
$38,355
Vanda Pharmaceuticals Inc.
$31,629
ABBVIE INC.
$30,084
Allergan Inc.
$25,372
Takeda Pharmaceuticals U.S.A., Inc.
$23,175
Allergan, Inc.
$10,341
ITI, Inc.
$8,696
IDORSIA PHARMACEUTICALS US INC
$7,924
Janssen Pharmaceuticals, Inc
$7,866
E.R. Squibb & Sons, L.L.C.
$3,616
Alkermes, Inc.
$1,422
Lundbeck LLC
$1,399
Neurocrine Biosciences, Inc.
$1,163
Teva Pharmaceuticals USA, Inc.
$788
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$361
Corium, LLC
$284
Shire North American Group Inc
$248
Eisai Inc.
$245
Axsome Therapeutics, Inc.
$193
JAZZ PHARMACEUTICALS INC.
$151
Supernus Pharmaceuticals, Inc.
$128
ARBOR PHARMACEUTICALS, INC.
$93
Indivior Inc.
$79
Bausch Health US, LLC
$76
Avanir Pharmaceuticals, Inc.
$67
Neos Therapeutics, LP
$60
Neuronetics, Inc.
$56
Ironshore Pharmaceuticals Inc.
$37
Biogen, Inc.
$32
Alfasigma USA, Inc.
$31
Otsuka Pharmaceutical Development & Commercialization, Inc.
$16
Sage Therapeutics, Inc.
$16
Noven Therapeutics, LLC
$14
Merck Sharp & Dohme Corporation
$13
Jazz Pharmaceuticals Inc.
$13
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · Dayvigo · Entyvio · Evekeo · FANAPT · HETLIOZ · Hetlioz · Horizant · INGREZZA · INVEGA SUSTENNA · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · Nuedexta · PERSERIS · QUVIVIQ · REXULTI · SPRAVATO · SUNOSI · Sunosi · TRINTELLIX · Trintellix · VIIBRYD · VRAYLAR · VYVANSE · Vyvanse · WELLBUTRIN · WELLBUTRIN XL · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for psychiatry in NY.

Looking for a psychiatry specialist in Buffalo?
Compare psychiatrists in the Buffalo area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Weinstein is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Weinstein experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Weinstein performed 217 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Weinstein receive payments from pharmaceutical companies?
Yes. Dr. Weinstein received a total of $408,217 from 37 companies across 1,568 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Weinstein's costs compare to other psychiatrists in Buffalo?
Dr. Weinstein's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Weinstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →